Background The unparalleled success of combination antiretroviral therapy (cART) is based
on the combination of three drugs from two classes. There is insufficient evidence whether …

While the mean age of HIV/AIDS patients at first diagnosis is progressively rising, no
updated epidemiological estimates, controlled clinical data, and randomized therapeutic …

Methods. We utilized a state-transition model of HIV disease to project life expectancy, costs,
and cost-effectiveness in a hypothetical cohort of antiretroviral-naive patients with chronic …

Background Changes in body fat distribution are an adverse effect of therapy with HIV
protease inhibitors (PI). It has been suggested that nucleoside analogue reverse …

The use of highly active antiretroviral therapy, the combination of at least three different
antiretroviral drugs for the treatment of HIV-1 infection, has greatly improved the prognosis …

Liver enzyme elevation (LEE) is commonly observed after combination antiretroviral therapy
(ARVT) for HIV infection is begun. Potential risk factors for LEE after treatment with ritonavir …

The mean age of patients at both first HIV detection and AIDS diagnosis is progressively
rising over time. However, reliable epidemiological estimates, clinical data or controlled …

Background Toxicity is the most important reason for premature switching of highly active
antiretroviral therapy (HAART). In order to optimize the benefit–risk ratio of HAART …

Objective To compare changes in quality of life (QoL) over 96 weeks in patients enrolled in a
triple-therapy protocol, a treatment-intensification protocol, or an induction-maintenance …

Objective To assess body composition changes in HIV-infected children receiving highly
active antiretroviral therapy (HAART). Methods Thirty-seven HIV-positive children were …